Bloomberg BusinessweekBloomberg Businessweek

Bloomberg Markets: Nierengarten on Small, Mid-Market Biotech

View descriptionShare
 

Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: David Nierengarten Head of Health Care Equity Research Wedbush Securities Discussing investing in biotech stocks, inlcuding Blueprint Medicines.

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Bloomberg Businessweek

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and  
Social links
Follow podcast
Recent clips
Browse 5,417 clip(s)